Surgery News and Research

RSS

Experts to discuss treatment options for wounded warriors at USU-HJF Military Medicine Symposium

The USU-HJF Military Medicine Symposium will gather prominent civilian and military researchers and clinicians from across the United States to discuss current research and identify opportunities to collaborate and share information that could speed treatments to wounded warriors. The symposium also will bring together a broad spectrum of participants from military health leadership, federal agencies and private research institutions to philanthropists and charitable foundations, representatives of industry, and policymakers.

28 Jul 2010

Northwest Hospital surgeon performs first robotic hand surgery in America

Stacey Berner, M.D., medical director of the Hand Center at Northwest Hospital in Randallstown, MD, has become the first surgeon in America to perform a revolutionary new robotic hand surgery.

28 Jul 2010

Research on impact of BCL2 markers on breast cancer tumours

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists.The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.

28 Jul 2010

Medtronic reports FDA Panel's affirmative votes on AMPLIFY rhBMP-2 Matrix for posterolateral spine fusion

The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and 10 for and 3 against (1 abstention) on effectiveness, that data including results from a large, prospective randomized clinical trial demonstrated the safety and effectiveness of AMPLIFY™ rhBMP-2 Matrix for fusions of the lower spine in patients with degenerative disc disease.

28 Jul 2010

Gulf Coast Medical Center to implement ProVation MD for GI procedure documentation and coding

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Gulf Coast Medical Center has selected its ProVation® MD software for gastroenterology procedure documentation and coding.

28 Jul 2010

USPTO grants two patents for Leto Medical's COS technology

Leto Medical, LLC, a privately held, early-stage medical device company, announced today that the United States Patent and Trademark Office has granted the company two patents (7,765,006 and 7,765,007) for its breakthrough Continent Ostomy System technology, a system of products that will restore continence control to individuals with colostomies.

28 Jul 2010

Clinicians in rural hospitals demonstrate high standard of care to patients: Study

Smaller, rural hospitals may be quicker and more efficient at implementing surgical safety initiatives than their larger, urban counterparts, and are capable of providing a standard of surgical care that is at par with major hospitals that provide a comprehensive array of care services, according to an 18-month series of studies led by researchers from the University of Louisville Department of Surgery.

28 Jul 2010

Researchers examine risk of serious complications associated with bariatric procedure

An examination of hospital complication rates of bariatric surgery for more than 15,000 patients in Michigan finds that the frequency of serious complications is relatively low and is inversely associated with hospital and surgeon procedural volume, according to a study in the July 28 issue of JAMA.

28 Jul 2010

CTC is not cost effective compared with colonoscopy: Study

A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).The cost effectiveness analysis concluded that CTC or virtual colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy

28 Jul 2010

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.

28 Jul 2010

Cancer survivor to celebrate 100th birthday

Loyola University Hospital cancer patient Mary Cipolla was 89 years old when she underwent one of the most extensive operations in surgery, known as the Whipple procedure.

28 Jul 2010

Cytori Therapeutics receives European approval for Celution System

Cytori Therapeutics received expanded European approval (CE Mark) for its Celution System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue. The new indications include key medical applications such as breast reconstruction, repair of soft tissue defects, as well as the facilitation of healing certain types of wounds, such as those resulting from Crohn's disease. This broadens Cytori's ability to offer the Celution System to patients and hospitals and further supports the company's efforts to gain treatment reimbursement.

28 Jul 2010

35 cases of hepatitis C among Melbourne abortion clinic patients

Over the last few months there has been a rise in hepatitis C cases at an abortion clinic in Melbourne. In a new development 13 new cases have been diagnosed. This brings the total count to 35. The Victorian police are investigating the source of the infections. The link between the Croydon Day Surgery and the cluster was first revealed in April, when there were only 12 cases.

28 Jul 2010

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.

28 Jul 2010

Research on method to open blood-brain barrier for safe cancer drug delivery

One of the human body's most powerful defensive tools, the blood-brain barrier is a chemical labyrinth that prevents toxins and viruses in the bloodstream from reaching the brain. This foolproof security system, however, limits the ability of physicians to deliver drugs directly to the brain, making it difficult to treat brain tumors. Researchers at Rensselaer Polytechnic Institute are endeavoring to solve this problem by investigating new methods for bypassing the blood-brain barrier and combating the spread of brain cancer.

28 Jul 2010

Growth in dental implant sales to propel bone-graft-substitute market

According to new dental reports by iData Research, the leading global authority in medical device, dental and pharmaceutical market research, the U.S. market for dental implants is expected to regain double-digit growth by 2013, and will help drive the dental prosthetic market to reach over 82 million prosthetic placements by 2016.

27 Jul 2010

New specially designed operatory for Oral Surgery, IV Sedation Dentistry

Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce that it has built a specially designed operatory to perform Oral Surgery and IV Sedation Dentistry. This opens a completely new element of dentistry because there are a tremendous amount of patients who require the sedation in order to perform these procedures.

27 Jul 2010

LCA-Vision second-quarter revenues decrease to $26.3 million

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three and six months ended June 30, 2010.

27 Jul 2010

Omeros initiates enrollment in OMS302 Phase 2b clinical trial in patients undergoing cataract surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.

27 Jul 2010

Studies that compare treatment options for carotid artery disease provide no clear answer, physician reports

A review of scientific studies that compares two treatments for preventing strokes due carotid artery disease provides no clear answer on which treatment is better, a UT Southwestern Medical Center physician reports in an editorial in today's issue of the Archives of Internal Medicine.

27 Jul 2010

Surgery News and Research

Experts to discuss treatment options for wounded warriors at USU-HJF Military Medicine Symposium

Northwest Hospital surgeon performs first robotic hand surgery in America

Research on impact of BCL2 markers on breast cancer tumours

Medtronic reports FDA Panel's affirmative votes on AMPLIFY rhBMP-2 Matrix for posterolateral spine fusion

Gulf Coast Medical Center to implement ProVation MD for GI procedure documentation and coding

USPTO grants two patents for Leto Medical's COS technology

Clinicians in rural hospitals demonstrate high standard of care to patients: Study

Researchers examine risk of serious complications associated with bariatric procedure

CTC is not cost effective compared with colonoscopy: Study

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

Cancer survivor to celebrate 100th birthday

Cytori Therapeutics receives European approval for Celution System

35 cases of hepatitis C among Melbourne abortion clinic patients

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Research on method to open blood-brain barrier for safe cancer drug delivery

Growth in dental implant sales to propel bone-graft-substitute market

New specially designed operatory for Oral Surgery, IV Sedation Dentistry

LCA-Vision second-quarter revenues decrease to $26.3 million

Omeros initiates enrollment in OMS302 Phase 2b clinical trial in patients undergoing cataract surgery

Studies that compare treatment options for carotid artery disease provide no clear answer, physician reports

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News